Symbol
LVTX
Investment type
Equity / Common shares, Euro 0.12 nominal value per share
Latest Disclosed Shares Owned
0 shares
Security Ownership %
0%

Versant Venture Capital VI, L.P. ownership in LAVA Therapeutics NV Common shares, Euro 0.12 nominal value per share (LVTX)

23 Sep 2025 - Versant Venture Capital VI, L.P. has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 0 shares of LAVA Therapeutics NV Common shares, Euro 0.12 nominal value per share (LVTX). This represents 0% ownership of the company. In their previous filing dated 18 Sep 2025, Versant Venture Capital VI, L.P. had reported owning 2,370,533 shares, indicating a decrease of +100%. .